SKYSTAR BIO-PHARMA COM USD0.001 (SKBI)

0.22
0.05 33.57
OTC
Prev Close 0.16
Open 0.16
Day Low/High 0.16 / 0.23
52 Wk Low/High 0.12 / 2.00
Volume 8.40K
Exchange OTC
Shares Outstanding 8.70B
Market Cap 1.40M
Div & Yield N.A. (N.A)

Latest News

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Moving The Health Care Sector Upward

3 Stocks Moving The Health Care Sector Upward

TheStreet highlights 3 stocks that pushed the Health Care sector

3 Stocks Driving The Drugs Industry Higher

3 Stocks Driving The Drugs Industry Higher

TheStreet highlights 3 stocks that pushed the Drugs industry

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Drugs Stocks Nudging The Industry Higher

3 Drugs Stocks Nudging The Industry Higher

TheStreet highlights 3 stocks that pushed the Drugs industry

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ARCX, FB, OMI, PERY, RCII, SGMS Downgrades: BLX, CUB, EVTC, IPCI, OFIX, SKBI, SNE, TTWO Initiations: AKAO, FSIC, OPB, SABR, TRIV, WB Read on to get TheStreet Quant Ratings' detailed report:

3 Stocks Under $10 Moving Higher

3 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Skystar Bio-Pharmaceutical (SKBI) Upgraded From Hold to Buy

Skystar Bio-Pharmaceutical (SKBI) Upgraded From Hold to Buy

Skystar Bio-Pharmaceutical (SKBI) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.

4 Stocks Under to Trade for Breakouts

4 Stocks Under to Trade for Breakouts

These under-$10 stocks are within range of triggering breakout trades.

The Next Big Biotech Mover: Ariad Pharma

The Next Big Biotech Mover: Ariad Pharma

Ariad Pharmaceuticals could be the next biotech stock setting up for a monster move higher, according to Roberto Pedone.

5 Stocks Ready to Explode Higher

5 Stocks Ready to Explode Higher

These stocks could be sett9ing up for explosive moves higher soon.

4 Biotech Stocks Under $10 Making Big Moves

4 Biotech Stocks Under $10 Making Big Moves

Keep these under-$10 biotech stocks on your radar.

Skystar Bio-Pharmaceutical Company Stock Upgraded (SKBI)

Skystar Bio-Pharmaceutical Company Stock Upgraded (SKBI)

Skystar Bio-Pharmaceutical Company (Nasdaq:SKBI) has been upgraded by TheStreet Ratings from a sell to hold.

Skystar Stock Soars (SKBI)

Shares of Skystar Bio-Pharmaceutical Company (Nasdaq:SKBI) have taken a tremendous swing upward. The stock is trading at $3 as of 3:56 p.m. ET, 35.1% above Friday's closing price of $2.22. Volume is at 64,862, 2.3 times the daily average of 28,700.

Two Undervalued China Pharma Stocks

Despite strong earnings growth, China Sky One Medical and Skystar Bio-Pharmaceuticals have experienced significant declines and are now presenting attractive buying opportunities.

China Growth: We Just Don't Care

These stocks will independently trounce any market average or unleveraged ETF in the next five years.

China Pharma Stocks Could Best U.S. Majors

Two undervalued pharmaceutical stocks from China could outperform U.S. drug giants Pfizer and Merck.

Top 50 Most Undervalued Stocks of 2010

We've researched 5,000 companies and arrived at 50 we believe to be the most undervalued.

Chinese Pharma Stocks Shine

Here are three exceptional Chinese pharmaceutical companies that are very undervalued compared to their U.S. counterparts.

Top Takes From RealMoney

Here's what some of our market pros are saying and playing.

Stock Gems From Asia

These Asian companies are good bets if you choose to own them at their current prices.

Catch the Wave in Chinese Micro-Caps

Lessons learned from trying to surf big water off Hawaii have given me some insight into investing in the Chinese micro-cap market.